Zeto Launches NeuroNotis™ for Enhanced AI-Driven Seizure Detection with Human Oversight

Zeto Unveils NeuroNotis™: A New Era in Seizure Detection



In an exciting development for healthcare, Zeto, Inc. has launched NeuroNotis™, a cutting-edge offering tailored for hospitals aiming to enhance confidence in seizure detection. This innovative product pairs the speed of AI with the careful oversight of experienced professionals, marking a significant advance in clinical healthcare.

The Need for Reliable Seizure Detection


As emergency rooms and critical care units increasingly turn to artificial intelligence for seizure detection, they face uncertainties when results hinge solely on machine-generated data. NeuroNotis™ addresses these concerns by integrating AI-generated seizure burden scores with validation from Registered EEG Technologists. This blending of technology with human review aims to facilitate faster and more informed clinical decisions.

The newly launched NeuroNotis Report offers hospitals rapid AI detection capabilities alongside real-time analysis performed by trained technologists. Reports are generated approximately 15 minutes following the first hour of recording, providing timely insights crucial for patient management.

Partnering for Precision


Delivered under a service agreement with Stratus, the leading EEG solutions provider in the country, the NeuroNotis Report harnesses the expertise of Stratus’ vast network of professionals. These qualified technologists validate AI findings during the critical first hour of EEG recording, lending credibility and reassurance to the data presented to healthcare providers.

Florian Strelzyk, CEO of Zeto, emphasizes the importance of this innovation, stating, “AI has made significant strides in seizure detection. However, several challenges still exist. NeuroNotis™ effectively combines our advanced AI with the expertise of seasoned neurodiagnostic professionals.”

Overcoming Challenges and Building Trust


Healthcare providers often struggle with the intricacies of machine learning algorithms. NeuroNotis stands as a solution that not only prioritizes speed but also maintains high-quality standards, alleviating concerns associated with trust and accountability in AI methods.

“As we push the boundaries of what AI can achieve in clinical settings,” Strelzyk adds, “the NeuroNotis Report assures physicians that every algorithmic finding is vetted by a human expert.” This fosters confidence in emergency settings, where timely and accurate data affects patient outcomes.

Seamless Integration into Clinical Workflow


NeuroNotis™ is designed to integrate effortlessly into hospitals’ existing workflows, enhancing the efficiency of clinical processes without additional financial burden. The service is cost-neutral, ensuring affordability while delivering high-quality EEG data. With this enhancement, Zeto continues its mission to provide scalable, real-time brain health insights, making high-quality EEG technology more accessible.

Future Directions


This launch coincides with Zeto’s recent unveiling of its New Wave system, aimed at outpatient and home EEG applications. Zeto is dedicated to expanding its offerings in the healthcare landscape, and NeuroNotis™ serves as a critical supplement to its flagship platform, Zeto ONE™.

The feedback from the clinical community has been overwhelmingly positive, reflecting the shift towards a more hybrid approach to interpretation combining AI insights with human judgment. As healthcare evolves, Zeto remains at the forefront, ensuring that the use of technology uplifts the standard of care while creating new possibilities in neurology.

About Zeto, Inc.


Zeto, Inc. leads the way in next-generation neurotechnology, aiming to integrate brain health insights into daily medical practices. The company’s FDA-cleared EEG platform enables real-time monitoring, ensuring that healthcare providers have access to actionable data for improved patient care. With ongoing innovations, Zeto seeks to redefine the landscape of medical EEG testing, ultimately positioning brain monitoring as essential as any vital sign.

To learn more about Zeto and its services, please visit zeto-inc.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.